FDA approves first ever medication for obstructive sleep apnea — here's what that means
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
The American Journal of Managed Care5d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
Medscape1d
Efficacy, Safety and Tolerability of Escitalopram in Doses up to 50 mg in Major Depressive Disorder (MDD)
Twenty-one patients (35%) achieved remission with 8 of the 21 patients (38%) needing the 50 mg dose to achieve remission. Median time to remission was 24 weeks and median dose in remission was 30 ...
Healthline5d
20 Sustainable Ways to Lose Weight in Your 30s
Your body changes over time. But you can do things in your 30s to aid weight loss and promote overall health, such as prioritizing fruits and vegetables, finding a form of exercise you enjoy, and ...
Bloomberg L.P.1d
Egyptian Exchange EGX 30 Price Index
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
SciELO4d
Synthesis by Click Reactions and Antiplasmodial Activity of Lupeol 1,2,3-Triazole Derivatives
In a round bottom flask, kept under nitrogen, a solution of lupeol, (200 mg, 0.469 mmol) in dry tetrahydrofuran (10 mL) was added under stirring NaH (56 g, 2.34 mmol). After 30 min, propargyl bromide ...
SciELO6d
Design, Synthesis, and Molecular Docking Studies of New Quinoline-Thiazole Hybrids, Potential Leads in the Development of Novel Antileukemic Agents
The Global Cancer Observatory project (GLOBOCAN) calculates 9.96 million deaths by cancer in 2020, and the World Health Organization (WHO) estimates a total burden of 30.2 million cases by 2040 with ...